Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Advanced Dry Macular Degeneration”

24 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 24 results

Testing effectiveness (Phase 2)UnknownNCT02590692
What this trial is testing

Study of Subretinal Implantation of Human Embryonic Stem Cell-Derived RPE Cells in Advanced Dry AMD

Who this might be right for
Dry Macular DegenerationGeographic Atrophy
Regenerative Patch Technologies, LLC 16
Not applicableStudy completedNCT04084587
What this trial is testing

Visual Rehabilitation Through Acoustic Biofeedback With Retimax Vision Trainer in Patients With Advanced Age-related Macular Degeneration

Who this might be right for
Macular Degeneration AdvancedMacular Degeneration, SenileMacular Degeneration, Dry+2 more
University of Modena and Reggio Emilia 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT02286089
What this trial is testing

Safety and Efficacy Study of OpRegen for Treatment of Advanced Dry-Form Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular Degeneration
Hoffmann-La Roche 24
Early research (Phase 1)Ended earlyNCT04002310
What this trial is testing

Test How Well Different Doses of BI 754132 Are Tolerated in Patients With an Advanced Form of Age-related Macular Degeneration Called Geographic Atrophy

Who this might be right for
Macular Degeneration
Boehringer Ingelheim 18
Early research (Phase 1)Study completedNCT03144999
What this trial is testing

Treatment of Advanced Dry Age Related Macular Degeneration With AAVCAGsCD59

Who this might be right for
Dry Age-related Macular Degeneration
Janssen Research & Development, LLC 17
Early research (Phase 1)Study completedNCT06006585
What this trial is testing

Test How Well Different Doses of BI 771716 Are Tolerated by People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

Who this might be right for
Geographic Atrophy
Boehringer Ingelheim 20
Testing effectiveness (Phase 2)UnknownNCT05380492
What this trial is testing

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-related Macular DegenerationGeographic Atrophy
Perceive Biotherapeutics, Inc. 45
Testing effectiveness (Phase 2)Looking for participantsNCT06557460
What this trial is testing

A Phase IIb Randomized, Multicenter Trial of Subretinal CPCB-RPE1 in Advanced Dry AMD (Geographic Atrophy)

Who this might be right for
Dry Age-related Macular DegenerationGeographic Atrophy
Regenerative Patch Technologies, LLC 24
Not applicableStudy completedNCT07428798
What this trial is testing

Subtenon PRP Injection for Geographic Atrophy in Dry Age-Related Macular Degeneration

Who this might be right for
Geographic AtrophyDry Age Related Macular Degeneration
Marmara University Pendik Training and Research Hospital 14
Testing effectiveness (Phase 2)Ended earlyNCT01674829
What this trial is testing

A PhaseI/IIa Study to Determine the Safety and Tolerability of MA09-hRPE Cells in Patients With Advanced Dry AMD

Who this might be right for
Dry Age Related Macular Degeneration
CHABiotech CO., Ltd 10
Not applicableStudy completedNCT02463344
What this trial is testing

Long Term Follow Up of Sub-retinal Transplantation of hESC Derived RPE Cells in Patients With AMD

Who this might be right for
Age-Related Macular Degeneration
Astellas Institute for Regenerative Medicine 11
Not applicableStudy completedNCT03451578
What this trial is testing

Alpha MSH in Ocular Disease

Who this might be right for
Advanced Dry Macular Degeneration
Duke University 54
Early research (Phase 1)Study completedNCT01835015
What this trial is testing

Pharmacokinetics of CLG561 in Patients With Advanced Age-Related Macular Degeneration

Who this might be right for
Age-related Macular Degeneration
Alcon Research 50
Early research (Phase 1)Study completedNCT01255462
What this trial is testing

Intravitreal LFG316 in Patients With Advanced Age-related Macular Degeneration

Who this might be right for
Advanced Age-related Macular Degeneration
Novartis Pharmaceuticals 24
Early research (Phase 1)UnknownNCT03305029
What this trial is testing

The Safety and Tolerability of Sub-retinal Transplantation of SCNT-hES-RPE Cells in Patients With Advanced Dry AMD

Who this might be right for
Dry Age Related Macular Degeneration
CHA University 3
Testing effectiveness (Phase 2)WithdrawnNCT04358471
What this trial is testing

Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)

Who this might be right for
Dry Age-related Macular DegenerationGeographic AtrophyGene Therapy+1 more
Hemera Biosciences
Testing effectiveness (Phase 2)Active Not RecruitingNCT06087458
What this trial is testing

Study of VOY-101 in Patients With Advanced Non-Neovascular Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationGeographic AtrophyNon-neovascular AMD+1 more
Perceive Biotherapeutics, Inc. 60
Testing effectiveness (Phase 2)Study completedNCT01445548
What this trial is testing

Sirolimus for Advanced Age-Related Macular Degeneration

Who this might be right for
Age-Related Macular DegenerationGeographic Atrophy
National Eye Institute (NEI) 6
Testing effectiveness (Phase 2)Active Not RecruitingNCT06722157
What this trial is testing

Test Whether BI 771716 Helps People With an Advanced Form of Age-related Macular Degeneration (AMD) Called Geographic Atrophy

Who this might be right for
Macular Degeneration, Age-relatedGeographic Atrophy
Boehringer Ingelheim 202
Early research (Phase 1)Study completedNCT01003691
What this trial is testing

Safety And Tolerability Study Of RN6G In Subjects With Advanced Dry, Age-Related Macular Degeneration Including Geographic Atrophy

Who this might be right for
Age-Related MaculopathyAge-Related MaculopathiesEye Diseases+2 more
Pfizer 24
Next Page